Skip to content

Hyoscine before hysteroscopy

Comparing injectable Hyoscine and vaginal misoprostol in cervical ripening before hysteroscopy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140224016705N13
Enrollment
120
Registered
2022-11-05
Start date
2022-05-22
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: cervical stenosis,. Condition 2: Endometrial polyp. Stricture and stenosis of cervix uteri Polyp of corpus uteri

Interventions

Intervention 1: Intervention group: Misoprostol.The people of this group are prescribed 200microgram of misoprostol single dose in the form of vaginal tablets on the morning of the surgery during the

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All people who underwent hysteroscopy in Mahdieh Hospital

Exclusion criteria

Exclusion criteria: People who are allergic to prostaglandins or hyoscine. People with a history of cervical injury or surgery. People with active cervical infection. Glaucoma History of cardiovascular disease and tachycardia People have recently been treated with estrogen. pregnancy

Design outcomes

Primary

MeasureTime frame
Cervical lacerations rate. Timepoint: during hysteroscopy. Method of measurement: presence of lacerations or canals.;Entrance of hysteroscope into cervix. Timepoint: Start of hysteroscopy. Method of measurement: Likert scale.;Uterine perforations. Timepoint: During surgery. Method of measurement: Based on serum deficit or surgeon experience.;Post-op pain/ use of analgesics. Timepoint: for 24 hours after procedure. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Drug side effects. Timepoint: 12 hours after drug administration. Method of measurement: based on patient vital signs and general conditions.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Zahra Heidar

Shahid Beheshti University of Medical Sciences

dr_zheidar@yahoo.com+98 21 5506 6288

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026